Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Four China COVID-19 Vaccines Safe in 60,000 Phase III Subjects
The reports come from trials that test vaccines from CanSino, Sinovac Biotech, Sinopharm-China National Biotec Group (CNBG), and the Wuhan Institute of Biological Products. Tian Baoguo, a senior official at
All together, there are eleven China-developed COVID-19 vaccines that have started trials, and many more that are in pre-clinical stage.
In addition, officials said people who received vaccines under emergency rules will not be included in trial. Several companies have started administering their vaccines to special groups, such as the ministry or business people travelling overseas.
See our other articles on COVID-19.